J Gynecol Oncol.  2009 Sep;20(3):158-163. 10.3802/jgo.2009.20.3.158.

Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases

Affiliations
  • 1Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Ankara, Turkey.
  • 2Department of Obstetrics and Gynecology, Hacettepe University Faculty of Medicine, Ankara, Turkey. csalman@hacettepe.edu.tr

Abstract


OBJECTIVE
Ovarian granulosa cell tumors are rare malignancies with a relatively favorable prognosis. However, patients still suffer from disease-related mortality. Therefore, the prognostic factors should be clarified. The purpose of this study was to investigate the clinical and pathologic characteristics related with disease recurrence and mortality in adult type ovarian granulosa cell tumors. METHODS: Eighty surgically staged patients with granulosa cell ovarian tumor treated at the Hacettepe University Hospital between 1982 and 2006 were retrospectively reviewed. Clinical and pathological characteristics were analyzed. RESULTS: Granulosa cell ovarian tumors accounted for 4.3% of malignant ovarian neoplasms. Mean age was 47.6 years. The most common presenting symptom was abnormal uterine bleeding (53.7%). Endometrial pathology was detected in 51.2% of patients preoperatively. Seventy percent of patients were diagnosed at stage I, and 53.8% of patients received adjuvant treatment. Mean follow-up was 67.5 months. Overall 5-year and 10-year survival was 91% and 86%, respectively. Mean survival was 147.1 months. Recurrence rate was 11.2%. In univariate analysis, advanced stage, advanced age, residual disease after surgery, and need for adjuvant treatment were associated with disease-related mortality and advanced stage disease and absence of initial staging surgery were associated with disease recurrence. However, in multivariate analysis, only initial stage was found to be a significant prognostic factor. CONCLUSION: Initial stage seems to be the single most important prognostic factor in ovarian granulosa cell tumors. Therefore, a comprehensive staging surgery should be attempted to document the real extent of disease and to estimate the oncologic outcome more accurately.

Keyword

Ovarian granulosa cell tumors; Prognostic factors; Recurrence; Mortality; Survival

MeSH Terms

Adult
Female
Follow-Up Studies
Granulosa Cell Tumor
Granulosa Cells
Humans
Multivariate Analysis
Ovarian Neoplasms
Prognosis
Recurrence
Retrospective Studies
Uterine Hemorrhage

Figure

  • Fig. 1 Survival curves according to initial stage of disease (A), age at diagnosis (B), presence or absence of macroscopic residual tumor (C), and adjuvant treatment status (D).


Reference

1. Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol. 1994. 52:50–55.
2. Segal R, DePetrillo AD, Thomas G. Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol. 1995. 56:338–344.
3. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol. 1996. 87:527–531.
4. Schwartz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol. 1976. 125:402–411.
5. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003. 21:1180–1189.
6. Cronje HS, Niemand I, Bam RH, Woodruff JD. Review of the granulosa-theca cell tumors from the emil Novak ovarian tumor registry. Am J Obstet Gynecol. 1999. 180:323–327.
7. Uygun K, Aydiner A, Saip P, Kocak Z, Basaran M, Dincer M, et al. Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecol Oncol. 2003. 88:400–403.
8. Uygun K, Aydiner A, Saip P, Basaran M, Tas F, Kocak Z, et al. Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol. 2003. 26:517–521.
9. Sehouli J, Drescher FS, Mustea A, Elling D, Friedmann W, Kuhn W, et al. Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Res. 2004. 24:1223–1229.
10. Evans AT 3rd, Gaffey TA, Malkasian GD Jr, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 1980. 55:231–238.
11. Pautier P, Lhomme C, Culine S, Duvillard P, Michel G, Bidart JM, et al. Adult granulosa-cell tumor of the ovary: a retrospective study of 45 cases. Int J Gynecol Cancer. 1997. 7:58–65.
12. Auranen A, Sundstrom J, Ijas J, Grenman S. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer. 2007. 17:1011–1018.
13. Homesley HD, Bundy BN, Hurteau JA, Roth LM. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol. 1999. 72:131–137.
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr